Keywords: مهارکنندههای بازجذب سروتونین; ECT; Electroconvulsive therapy; HDRS; Hamilton Depression Rating Scale-21; CGI-I; Clinical Global Impressions Improvement; IMI; imipramine; CPZ; chlorpromazine; SGA; second-generation antipsychotic; TCA; tricyclic antidepressant; SSRI; selective serotonin
مقالات ISI مهارکنندههای بازجذب سروتونین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکنندههای بازجذب سروتونین; IELT; intravaginal ejaculatory latency time; PE; premature ejaculation; PEDT; Premature Ejaculation Diagnostic Tool; SSRI; selective serotonin reuptake inhibitor; Circumcision; Excessive prepuce; Penile hypersensitivity; Premature ejaculation; Risk factor
Keywords: مهارکنندههای بازجذب سروتونین; Depression; Aging; Geriatrics; Perfusion; MRI; Ssri;
Keywords: مهارکنندههای بازجذب سروتونین; MÏs; macrophages; MAO-A; monoamine oxidase-A; SNRI; serotonin-norepinephrine re-uptake inhibitors; SSRI; selective serotonin re-uptake inhibitors; TCA; tricyclic antidepressant drugs; Antidepressant drugs; Immune regulation; Immune suppression; Macrophag
Keywords: مهارکنندههای بازجذب سروتونین; BDNF; Brain-derived neurotrophic factor; IL; Interleukin; LPS; Lipopolysaccharide; MDD; Major depression disorder; NHT; Novel herbal treatment; SSRI; Selective serotonin reuptake inhibitor; VEH; Vehicle control; Endotoxin; Proinflammatory cytokine; Sickne
Keywords: مهارکنندههای بازجذب سروتونین; AS; anxiety sensitivity; PD; panic disorder; MBCT; Mindfulness-Based Cognitive Therapy; SSRI; selective serotonin re-uptake inhibitor; HC; healthy control; WM; white matter; SD; standard deviation; DSM-IV-TR; Diagnostic and Statistical Manual of Mental Di
Keywords: مهارکنندههای بازجذب سروتونین; ANS; autonomic nervous system; BMI; body mass index; BP; blood pressure; CVD; cardiovascular disease; ECG; electrocardiogram; HR; heart rate; HRV; heart rate variability; IAT; implicit association task; IBI; interbeat interval; ICG; impedance cardiography
Keywords: مهارکنندههای بازجذب سروتونین; Buprenorphine; methadone; pregnancy; neonatal abstinence syndrome; ADGs; ambulatory diagnostic groups; CIHI; Canadian Institute for Health Information; GA; gestational age; ICES; Institute for Clinical Evaluative Sciences; NAS; neonatal abstinence syndrom
Keywords: مهارکنندههای بازجذب سروتونین; MDD; major depressive disorder; BD; bipolar disorder; BD-I; bipolar I disorder; BD-II; bipolar II disorder; HC; healthy controls; VBM; voxel-based morphometry; SBM; surface-based morphometry; GM; gray matter; WM; white matter; CSF; cerebrospinal fluid; CT
Keywords: مهارکنندههای بازجذب سروتونین; 11β-HSD2; 11β-hydroxysteroid dehydrogenase type 2; FA; fractional anisotropy; HPA; hypothalamic-pituitary-adrenal; IVH; intraventricular hemorrhage; RD; radial diffusivity; ROIs; regions of interest; SNAP-PE; Score for Neonatal Acute Physiology-Peri
Keywords: مهارکنندههای بازجذب سروتونین; Obsessive slowness; Catatonia; OCD; Management; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; Depression; Cardiovascular disease; Coronary atherosclerosis; SSRI; Nonhuman primate; Anterior cingulate cortex; Hippocampus; MRI;
Keywords: مهارکنندههای بازجذب سروتونین; amitriptyline; antidepressant; doxepin; itch; paroxetine; pruritus; systemic treatment; RCT; randomized controlled trial; SSRI; selective serotonin reuptake inhibitor; TCA; tricyclic antidepressant; VAS; Visual Analogue Scale;
Keywords: مهارکنندههای بازجذب سروتونین; SUDEP; sudden unexpected death in epilepsy; MORTEMUS; Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units; GTCS; generalised tonic-clonic seizure; PGES; postictal generalised EEG suppression; AED; antiepileptic drug; NICE; N
Keywords: مهارکنندههای بازجذب سروتونین; AE; adverse event; CDSR; Cochrane Database of Systematic Reviews; COMTI; catechol-O-methyltransferase inhibitor; DOPA; dopamine; FDA; Food and Drug Administration; GABA; γ-aminobutyric acid; GnRH; gonadotropin-releasing hormone; IQR; interquartile range;
Keywords: مهارکنندههای بازجذب سروتونین; AD; anxiety disorder; TRD; treatment resistant depression; MDD; major depressive disorder; MINI; Mini International Neuropsychiatric Interview; IPSM; Interpersonal Sensitivity Measure; OR; odds ratio; PD; panic disorder; PTSD; posttraumatic stress disorde
Keywords: مهارکنندههای بازجذب سروتونین; Obesity; Pharmacotherapy; Weight Management; Testosterone; BMI; body mass index; ER; extended-release; FDA; Food and Drug Administration; SSRI; selective serotonin reuptake inhibitor;
Keywords: مهارکنندههای بازجذب سروتونین; OCD; obsessive compulsive disorder; OCS; obsessive compulsive symptoms; SSRI; selective serotonin reuptake inhibitor; SCID I; structured clinical interview for DSM-IV, Axis I; HDRS; Hamilton Depression Rating Scale; PANSS; positive and negative syndrome s
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Fluoxetine; Prenatal stress; Development; Female; Behaviour;
Keywords: مهارکنندههای بازجذب سروتونین; Kappa opioid receptor; Serotonin; Clearance; Serotonin transporter; Phosphorylation; Trafficking; 5-HT; 5-hydroxytryptamine (serotonin); Akt X; Akt inhibitor X (10-(4â²-(N-diethylamino)butyl)-2-chlorophenoxazine); Akt; protein kinase B/Akt; BNI; nor-bina
Keywords: مهارکنندههای بازجذب سروتونین; PTSD; post-traumatic stress disorder; mSPS; mouse single prolonged stress; VLX; venlafaxine; CLO; clonidine; SSRI; selective serotonin reuptake inhibitors; hDAT; human dopamine transporter; hNET; human norepinephrine transporter; hSERT; human serotonin tr
Keywords: مهارکنندههای بازجذب سروتونین; Expectancies; SSRI; Social anxiety disorder; Placebo effect; Neuroimaging; fMRI;
Keywords: مهارکنندههای بازجذب سروتونین; 5-HIAA; 5-hydroxyindoleacetic acid, main 5-HT metabolite; 5-HT; 5-hydroxytryptamine, serotonin; EF; executive functioning; G Ã E; Gene Ã Environment (interactions); HPA; hypothalamic-pituitary-adrenal; MAO; monoamine oxidase; SERT; 5-HT transporte
Keywords: مهارکنندههای بازجذب سروتونین; MDD; Major Depressive Disorder; SSRI; selective-serotonin reuptake inhibitor; CS; conditioned stimulus; US; unconditioned stimulus; PNN; perineuronal net; DG; dentate gyrus; WFA; wisteria floribunda agglutinin; PBS; phosphate buffered saline; PFA; parafor
Keywords: مهارکنندههای بازجذب سروتونین; AL; ad libitum; DD; dark-dark conditions; FAA; food anticipatory activity; FEO; food-entraiable oscillator; FLX; fluvoxamine; LD; light-dark conditions; PCPA; parachlorophenylalanine; RF; restricted feeding; SCN; suprachiasmatic nuclei; SSRI; selectiv
Keywords: مهارکنندههای بازجذب سروتونین; HDAC; histone deacetylase; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin noradrenaline reuptake inhibitor; BDNF; Brain-derived neurotrophic factor; GDNF; glial cell line-derived neurotrophic factor; FEGF; vascular endothelial growth factor
Keywords: مهارکنندههای بازجذب سروتونین; Spexin; Escitalopram; SSRI; Neuropeptides; Brain;
Keywords: مهارکنندههای بازجذب سروتونین; Dapoxetine; Safety; Cardiovascular Events; SSRI; Paroxetine; Fluoxetine
Keywords: مهارکنندههای بازجذب سروتونین; ALA; alpha-lipoic acid; CAT; catalase; CORT; corticosterone; DVS; desvenlafaxine; GSH; reduced glutathione; HC; hippocampus; LP; lipid peroxidation; MDA; malondialdehyde; MDD; major depressive disorder; PMD; psychotic major depression; PFC; prefrontal cor
Keywords: مهارکنندههای بازجذب سروتونین; N. menthoides; Nepeta menthoides Boiss. & Buhse; BDI-II; Beck Depression Inventory second version; SD; standard deviation; BMI; body mass index; SUMS; Shiraz University of Medical Sciences; SSRI; selective serotonin reuptake inhibitor; MDD; major depressi
Keywords: مهارکنندههای بازجذب سروتونین; CCR5; CD4; CXCR4; Depression; HIV; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; OCD; obsessive-compulsive disorder; SSRI; selective serotonin reuptake inhibitors; ERPs; event-related potentials; ADHD; attention deficit/hyperactivity disorder; MMN; mismatch negativity; SCID-NP; Structured Clinical Interview for DSM-IV Axis Disorders,
Keywords: مهارکنندههای بازجذب سروتونین; DEB; dream enactment behavior; DLB; dementia with Lewy bodies; NREM; non-rapid eye movement; OSA; obstructive sleep apnea; PD; Parkinson disease; PSG; polysomnography; RBD; rapid eye movement sleep behavior disorder; REM; rapid eye movement; SSRI; selec
Keywords: مهارکنندههای بازجذب سروتونین; ADHD; Attention deficit hyperactivity disorder; FDA; Food and Drug Administration; PTSD; Posttraumatic stress disorder; SSRI; Selective serotonin reuptake inhibitor;
Keywords: مهارکنندههای بازجذب سروتونین; AGS; American Geriatrics Society; CBT; cognitive behavioral therapy; FDA; Food and Drug Administration; SSRI; selective serotonin reuptake inhibitor;
Keywords: مهارکنندههای بازجذب سروتونین; Serotonin transporter; Allosteric; SSRI; Marble burying; Tail suspension test; Escitalopram
Keywords: مهارکنندههای بازجذب سروتونین; MI; myocardial infarction; SSRI; selective serotonin reuptake inhibitor; LPS; lipopolysaccharide; IL; interleukin; MMP; matrix metalloproteinase; TIMP; tissue inhibitor of metalloproteinase; CIT; citalopram; LAD; left anterior descending coronary artery;
Keywords: مهارکنندههای بازجذب سروتونین; Social phobia; 5-HT; NK1; Positron emission tomography; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; ABC; Aberrant Behavior Checklist; ADI-R; Autism Diagnostic Interview-Revised; ASD; autism spectrum disorder; BPI-01; Behavior Problems Inventory-01; CGI; Clinical Global Impressions; CGI-I; Clinical Global Impressions-Improvement; CGI-S; Clinical Global I
Keywords: مهارکنندههای بازجذب سروتونین; Serotonin; SSRI; Metabolism; Fat; ACC; FAS; PP2A;
Keywords: مهارکنندههای بازجذب سروتونین; Antidepressant; SSRI; Environment; Major depression; Plasticity; Serotonin; Undirected susceptibility to change hypothesis; Microglia; Inflammation; Cytokines;
Keywords: مهارکنندههای بازجذب سروتونین; AUC; area under the curve; CPIC; Clinical Pharmacogenetics Implementation Consortium; CYP; cytochrome P450; EM; extensive metabolizer; FDA; US Food and Drug Administration; OCD; obsessive-compulsive disorder; PM; poor metabolizer; QIDS-C16; Quick Inventor
Keywords: مهارکنندههای بازجذب سروتونین; Serotonin uptake inhibitors; SSRI; Antidepressive agents; Antidepressants; Pregnancy; Autistic disorder; Autism spectrum disorder; Autism;
Keywords: مهارکنندههای بازجذب سروتونین; FLX; fluoxetine; HPA; hypothalamic pituitary-adrenal axis; SSRI; selective serotonin reuptake inhibitor; PND; postnatal day; CORT; corticosterone; ANOVA; analysis of variance; SEM; standard error of the mean; Prenatal stress; HPA axis; Pregnancy; Antidepr
Keywords: مهارکنندههای بازجذب سروتونین; 5-HT; Serotonin; BDNF; Brain-derived neurotrophic factor; CRP; C reactive protein; CVD; Cardiovascular disease; CRF; Corticotrophin-releasing factor; DA; Dopamine; DR; Dorsal raphe; INF; Interferon; IL; Interleukin; IL-1Ra; Interleukin 1 receptor antagoni
Keywords: مهارکنندههای بازجذب سروتونین; CBT; cognitive behavioral therapy; CYP2D6; cytochrome P450 2D6; DHEA; dehydroepiandrosterone; FDA; Food and Drug Administration; GSM; genitourinary syndrome of menopause; MPA; medroxyprogesterone acetate; SERM; selective estrogen receptor modulator; SGB;
Keywords: مهارکنندههای بازجذب سروتونین; Panic; Agoraphobia; CBT; SSRI; fMRI; Westphal-Paradigm;
Keywords: مهارکنندههای بازجذب سروتونین; DD; defecatory disorder; GI; gastrointestinal; 5-HT; 5-hydroxytryptamine; IBS; irritable bowel syndrome; NBS; narcotic bowel syndrome; OBD; opioid bowel dysfunction; OIC; opioid-induced constipation; SNRI; serotonin and norepinephrine reuptake inhibitor;
Keywords: مهارکنندههای بازجذب سروتونین; 5-HT; Serotonin; BMI; Body Mass Index; CBT; Cognitive Behavioural Therapy; CEE; Conjugated Equine Estrogen; CES-D; Centre for Epidemiological Studies of Depression scale; CI; Confidence Interval; CVD; Cardiovascular Disease; DSM-IV; Diagnostic and Statist
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; selective serotonin reuptake inhibitor; ASD; Autism spectrum disorder; OR; odds ratios; CI; confidence intervals; MOOSE; meta-analysis of observational studies in epidemiology; PRISMA; preferred reporting items for systematic reviews and meta-analys